Since the 90s we have specialized in „Translational Sciences” – Implementing projects across traditional intersections from research to medicines ready for the market.
Current PMD activities focus on two projects sparked by Covid-19. Learn more about our current projects Aurovir and V-Risk, and further PMD activities.
At present PMD is looking for partners in clinical development and production of aurovir, partners in marketing and investors.